Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Terashima

Showing results (291-300 of 297) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 297 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 24, 2015
An activating ALK gene mutation in ALK IHC-positive/FISH-negative nonsmall-cell lung cancerY Togashi, H Mizuuchi, Y Kobayashi, et al.
British Journal of Cancer|March 17, 2005
Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasisM Terashima, C Maesawa, K Oyama, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2015
Phase II/III study of second-line chemotherapy comparing irinotecan-alone with S-1 plus irinotecan in advanced gastric cancer refractory to first-line treatment with S-1 (JACCRO GC-05)K Tanabe, M Fujii, K Nishikawa, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
ARCAD-Asia initiative: leveraging yesterday's data for tomorrowY Takeda, T Misumi, H Bando, et al.
Journal of the National Cancer Institute|April 6, 2000
E-Cadherin gene promoter hypermethylation in primary human gastric carcinomasG Tamura, J Yin, S Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2015
Clinical application of amplicon-based next-generation sequencing to therapeutic decision making in lung cancerM Takeda, K Sakai, M Terashima, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 26, 2024
Revisiting the use of the EORTC QLQ-STO22 to assess health-related quality of life of patients with gastric cancer: incorporating updated treatment options and cross-cultural perspectivesS C Sodergren, A Hurley-Wallace, V Vassiliou, et al.
Pageof 30

Showing results (291-300 of 297) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 297 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 24, 2015
An activating ALK gene mutation in ALK IHC-positive/FISH-negative nonsmall-cell lung cancerY Togashi, H Mizuuchi, Y Kobayashi, et al.
British Journal of Cancer|March 17, 2005
Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasisM Terashima, C Maesawa, K Oyama, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2015
Phase II/III study of second-line chemotherapy comparing irinotecan-alone with S-1 plus irinotecan in advanced gastric cancer refractory to first-line treatment with S-1 (JACCRO GC-05)K Tanabe, M Fujii, K Nishikawa, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
ARCAD-Asia initiative: leveraging yesterday's data for tomorrowY Takeda, T Misumi, H Bando, et al.
Journal of the National Cancer Institute|April 6, 2000
E-Cadherin gene promoter hypermethylation in primary human gastric carcinomasG Tamura, J Yin, S Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2015
Clinical application of amplicon-based next-generation sequencing to therapeutic decision making in lung cancerM Takeda, K Sakai, M Terashima, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 26, 2024
Revisiting the use of the EORTC QLQ-STO22 to assess health-related quality of life of patients with gastric cancer: incorporating updated treatment options and cross-cultural perspectivesS C Sodergren, A Hurley-Wallace, V Vassiliou, et al.
Pageof 30